← Evidence map

ArticleClinical proteomics2020

A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease.

Scott Bringans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33093819